BACKGROUND:home-based telecare (TC) is utilised to manage risks of independent living and provide prompt emergency responses. This study examined the effect of TC on health-related quality of life (HRQoL), anxiety and depressive symptoms over 12 months in patients receiving social care. DESIGN: a study of participant-reported outcomes [the Whole Systems Demonstrator (WSD) Telecare Questionnaire Study; baseline n = 1,189] was nested in a pragmatic cluster-randomised trial of TC (the WSD Telecare trial), held across three English Local Authorities. General practice (GP) was the unit of randomisation and TC was compared with usual care (UC). METHODS: participant-reported outcome measures were collected at baseline, short-term (4 months) and long-term (12 months) follow-up, assessing generic HRQoL, anxiety and depressive symptoms. Primary intention-to-treat analyses tested treatment effectiveness and were conducted using multilevel models to control for GP clustering and covariates for participants who completed questionnaire measures at baseline assessment plus at least one other assessment (n = 873). RESULTS: analyses found significant differences between TC and UC on Short Form-12 mental component scores (P < 0.05), with parameter estimates indicating being a member of the TC trial-arm increases mental component scores (UC-adjusted mean = 40.52; TC-adjusted mean = 43.69). Additional significant analyses revealed, time effects on EQ5D (decreasing over time) and depressive symptoms (increasing over time). CONCLUSIONS:TC potentially contributes to the amelioration in the decline in users' mental HRQoL over a 12-month period. TC may not transform the lives of its users, but it may afford small relative benefits on some psychological and HRQOL outcomes relative to users who only receive UC. International Standard Randomised Controlled Trial Number Register: ISRCTN 43002091.
RCT Entities:
BACKGROUND: home-based telecare (TC) is utilised to manage risks of independent living and provide prompt emergency responses. This study examined the effect of TC on health-related quality of life (HRQoL), anxiety and depressive symptoms over 12 months in patients receiving social care. DESIGN: a study of participant-reported outcomes [the Whole Systems Demonstrator (WSD) Telecare Questionnaire Study; baseline n = 1,189] was nested in a pragmatic cluster-randomised trial of TC (the WSD Telecare trial), held across three English Local Authorities. General practice (GP) was the unit of randomisation and TC was compared with usual care (UC). METHODS:participant-reported outcome measures were collected at baseline, short-term (4 months) and long-term (12 months) follow-up, assessing generic HRQoL, anxiety and depressive symptoms. Primary intention-to-treat analyses tested treatment effectiveness and were conducted using multilevel models to control for GP clustering and covariates for participants who completed questionnaire measures at baseline assessment plus at least one other assessment (n = 873). RESULTS: analyses found significant differences between TC and UC on Short Form-12 mental component scores (P < 0.05), with parameter estimates indicating being a member of the TC trial-arm increases mental component scores (UC-adjusted mean = 40.52; TC-adjusted mean = 43.69). Additional significant analyses revealed, time effects on EQ5D (decreasing over time) and depressive symptoms (increasing over time). CONCLUSIONS:TC potentially contributes to the amelioration in the decline in users' mental HRQoL over a 12-month period. TC may not transform the lives of its users, but it may afford small relative benefits on some psychological and HRQOL outcomes relative to users who only receive UC. International Standard Randomised Controlled Trial Number Register: ISRCTN 43002091.
Authors: Rebecca Gathercole; Rosie Bradley; Emma Harper; Lucy Davies; Lynn Pank; Natalie Lam; Anna Davies; Emma Talbot; Emma Hooper; Rachel Winson; Bethany Scutt; Victoria Ordonez Montano; Samantha Nunn; Grace Lavelle; Matthew Lariviere; Shashivadan Hirani; Stefano Brini; Andrew Bateman; Peter Bentham; Alistair Burns; Barbara Dunk; Kirsty Forsyth; Chris Fox; Catherine Henderson; Martin Knapp; Iracema Leroi; Stanton Newman; John O'Brien; Fiona Poland; John Woolham; Richard Gray; Robert Howard Journal: Health Technol Assess Date: 2021-03 Impact factor: 4.014
Authors: Catherine Henderson; Martin Knapp; José-Luis Fernández; Jennifer Beecham; Shashivadan P Hirani; Michelle Beynon; Martin Cartwright; Lorna Rixon; Helen Doll; Peter Bower; Adam Steventon; Anne Rogers; Ray Fitzpatrick; James Barlow; Martin Bardsley; Stanton P Newman Journal: Age Ageing Date: 2014-06-20 Impact factor: 10.668
Authors: Frederic Vannieuwenborg; Thomas Van der Auwermeulen; Jan Van Ooteghem; An Jacobs; Sofie Verbrugge; Didier Colle Journal: JMIR Med Inform Date: 2016-10-31
Authors: Ilaria Mosca; Philip J van der Wees; Esther S Mot; Joost J G Wammes; Patrick P T Jeurissen Journal: Int J Health Policy Manag Date: 2017-04-01
Authors: Adam Steventon; Martin Bardsley; Helen Doll; Elizabeth Tuckey; Stanton P Newman Journal: BMC Health Serv Res Date: 2014-08-06 Impact factor: 2.655